Our partner Shenzhen JY Med Technologies Co, Ltd. has a broad portfolio of active pharmaceutical ingredients ( API = active pharmaceutical ingredient ). All API antibiotics are made strictly under cGMP ("Good manufacturing practices"). Periodic audits of national (CFDA) and international authorities as well as customer audits are held, too. You are welcome to discuss your needs in Germany or to visit us in China, as well !
Download: API Flyer JYMedtech
For research use only. Products currently covered by valid US Patents or any other patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.
MC Infect Dis. 2016; 16: 490.
Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study
Patrick J. van der Geest, Nicole G. M. Hunfeld, Sophie E. Ladage, and A. B. Johan Groeneveld .
Clin Infect Dis. 2007 Oct 1;45(7):883-
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, Vazquez JA, Dupont BF, Horn DL, Ostrosky-
Antibiotics for Research
We will provide you with an price offer on request. Please indicate your companies name and your position within. Contact us by email: info@genosphere-
|humanes ANP (1-28)|
|Matrikine - OEM|
|Cosmetic Peptides - OEM|